LGI1 Antibody

O95970

LGI1 Antibody: The leucine-rich, glioma inactivated gene 1 (LGI1) was first identified as a candidate tumor suppressor gene for glioma and may play a role in other cancers. LGI1 is a member of a family of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 serves as a ligand to ADAM22, a metalloprotease localized at the synapse. Mutations in LGI1 account for nearly half of autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Two isoforms of LGI1 are known to exist, but the top band seen in the western blot is likely to be non-specific. This LGI1 antibody is predicted to be specific to LGI1 and not recognize other LGI proteins.

Polyclonal

LGI1

Western blot analysis of LGI1 in mouse brain tissue lysate with LGI1 antibody at 1 µg/mL in (A) the absence and (B) the presence of blocking peptide.

AAQ89244; 37182888

63818

LGI1;

LGI1 antibody can be stored at 4℃ for three months and -20℃, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

LGI1 antibody can be used for the detection of LGI1 by Western blot at 1 µg/mL.

LGI1 Antibody is supplied in PBS containing 0.02% sodium azide.